Allotex

Corneal Allografts for the treatment of presbyopia, hyperopia, myopia, and astigmatism

placeZurich, Zurich, Switzerland calendar_todayFounded 2016 language allotex.com

Innovation

5 patent families (4 granted) — focus: Human necessities, Operations & transport; filing pace slowing. Cited 667 times.

YearFilings
20181
20194
20203
20212
20222
20232
20241
20251
20261

Social engagement

Social engagement: 2.4K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include KCK MedTech, Junson Capital.

Investor typeCountShare
Venture capital360%
Angel & family office120%
Other / undisclosed120%

Recent activity

30 Jun 2026
Event
BSRS Annual Conference
26 Jun 2026
Event
7th Corneal Allograft Course for Presbyopia and Keratoconus
25 Jun 2026
Event
ESCRS
Coming soon